Landmark Publication on Vitamin C for COVID-19

While health authorities and mainstream media have ignored, if not outright opposed, the use of vitamin C and other supplements in the treatment of COVID-19, citing lack of clinical evidence, a landmark review recommends the use of vitamin C as an adjunctive therapy for respiratory infections, sepsis and COVID-19

According to the authors, “Vitamin C’s antioxidant, anti-inflammatory and immunomodulating effects make it a potential therapeutic candidate, both for the prevention and amelioration of COVID-19 infection, and as an adjunctive therapy in the critical care of COVID-19”

Oral vitamin C at doses of 2 to 8 grams a day have been shown to reduce the incidence and duration of respiratory infections

Intravenous vitamin C at 6 to 24 grams a day has been shown to reduce mortality, ICU admission rates, hospital stays and time on mechanical ventilation in patients with severe respiratory infections

An international vitamin C campaign has been launched in response to the landmark review

Dr Mercola Landmark Publication on Vitamin C for COVID-19